JP2005511595A5 - - Google Patents

Download PDF

Info

Publication number
JP2005511595A5
JP2005511595A5 JP2003541839A JP2003541839A JP2005511595A5 JP 2005511595 A5 JP2005511595 A5 JP 2005511595A5 JP 2003541839 A JP2003541839 A JP 2003541839A JP 2003541839 A JP2003541839 A JP 2003541839A JP 2005511595 A5 JP2005511595 A5 JP 2005511595A5
Authority
JP
Japan
Prior art keywords
phenyl
hal
methanoyl
hydrazono
pyridazin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003541839A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005511595A (ja
JP5116940B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2002/011351 external-priority patent/WO2003039548A1/en
Publication of JP2005511595A publication Critical patent/JP2005511595A/ja
Publication of JP2005511595A5 publication Critical patent/JP2005511595A5/ja
Application granted granted Critical
Publication of JP5116940B2 publication Critical patent/JP5116940B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2003541839A 2001-11-05 2002-10-10 ヒドラゾノ−マロニトリル類 Expired - Fee Related JP5116940B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP01125455 2001-11-05
EP01125455.4 2001-11-05
PCT/EP2002/011351 WO2003039548A1 (en) 2001-11-05 2002-10-10 Hydrazono-malonitriles

Publications (3)

Publication Number Publication Date
JP2005511595A JP2005511595A (ja) 2005-04-28
JP2005511595A5 true JP2005511595A5 (https=) 2012-10-04
JP5116940B2 JP5116940B2 (ja) 2013-01-09

Family

ID=8179075

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003541839A Expired - Fee Related JP5116940B2 (ja) 2001-11-05 2002-10-10 ヒドラゾノ−マロニトリル類

Country Status (19)

Country Link
US (2) US7141572B2 (https=)
EP (1) EP1441730B1 (https=)
JP (1) JP5116940B2 (https=)
KR (1) KR100898894B1 (https=)
CN (1) CN1585641A (https=)
AR (1) AR040629A1 (https=)
AT (1) ATE335486T1 (https=)
AU (1) AU2002363368B2 (https=)
BR (1) BR0213683A (https=)
CA (1) CA2465746C (https=)
DE (1) DE60213841T2 (https=)
ES (1) ES2268157T3 (https=)
HU (1) HUP0401747A3 (https=)
MX (1) MXPA04004263A (https=)
MY (1) MY129491A (https=)
PL (1) PL369738A1 (https=)
RU (1) RU2302412C2 (https=)
WO (1) WO2003039548A1 (https=)
ZA (1) ZA200404387B (https=)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA82323C2 (uk) * 2002-08-09 2008-04-10 Меда Фарма Гмбх & Ко. Кг Нова комбінація глюкокортикоїду та pde-інгібітору для лікування респіраторних захворювань, алергічних захворювань, астми та хронічних обструктивних легеневих захворювань
AU2003300076C1 (en) 2002-12-30 2010-03-04 Angiotech International Ag Drug delivery from rapid gelling polymer composition
WO2004067006A1 (en) * 2003-01-27 2004-08-12 Pharmacia Corporation Combination of a pde iv inhibitor and a tnf-alpha antagonist
WO2004087641A1 (ja) * 2003-03-31 2004-10-14 Daiichi Pharmaceutical Co., Ltd. ヒドラゾン誘導体
PE20060272A1 (es) * 2004-05-24 2006-05-22 Glaxo Group Ltd (2r,3r,4s,5r,2'r,3'r,4's,5's)-2,2'-{trans-1,4-ciclohexanodiilbis-[imino(2-{[2-(1-metil-1h-imidazol-4-il)etil]amino}-9h-purin-6,9-diil)]}bis[5-(2-etil-2h-tetrazol-5-il)tetrahidro-3,4-furanodiol] como agonista a2a
JP2008536888A (ja) * 2005-04-19 2008-09-11 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング 肺高血圧症の治療のためのロフルミラスト
GB0514809D0 (en) 2005-07-19 2005-08-24 Glaxo Group Ltd Compounds
PL2007752T3 (pl) 2006-03-31 2011-02-28 Janssen Pharmaceutica Nv Benzoimidazol-2-ilopirymidyny i pirazyny jako modulatory receptora histaminowego H4
US9371311B2 (en) 2008-06-30 2016-06-21 Janssen Pharmaceutica Nv Benzoimidazol-2-yl pyrimidine derivatives
AU2009314072C1 (en) 2008-11-15 2016-11-10 Melinta Subsidiary Corp. Antimicrobial compositions
US20120301463A1 (en) 2009-09-30 2012-11-29 President And Fellows Of Harvard College Methods for Modulation of Autophagy Through the Modulation of Autophagy-Enhancing Gene Products
US8440655B2 (en) * 2010-06-21 2013-05-14 Theracos, Inc. Combination therapy for the treatment of diabetes
US9446131B2 (en) 2013-01-31 2016-09-20 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
US8778365B1 (en) 2013-01-31 2014-07-15 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
US9452173B2 (en) 2013-01-31 2016-09-27 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
US9433680B2 (en) 2013-01-31 2016-09-06 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
BR112015019276A2 (pt) 2013-02-19 2017-07-18 Pfizer compostos de azabenzimidazol como inibidores de isoenzimas de pde4 para o tratamento de distúrbios do snc e outros distúrbios
SMT202000084T1 (it) * 2013-03-06 2020-03-13 Janssen Pharmaceutica Nv Modulatori benzoimidazol-2-il pirimidinici del recettore h4 dell'istamina
WO2015054359A1 (en) * 2013-10-08 2015-04-16 Ebadi Mark A Methods and compositions for symptomatic reflief of the common cold
WO2016012896A1 (en) 2014-07-24 2016-01-28 Pfizer Inc. Pyrazolopyrimidine compounds
MD20170011A2 (ro) 2014-08-06 2017-08-31 Pfizer Inc. Compuşi imidazopiridazinici
WO2016149126A1 (en) 2015-03-13 2016-09-22 The Board Of Trustees Of The Leland Stanford Junior University Ltb4 inhibition to prevent and treat human lymphedema
US11116737B1 (en) 2020-04-10 2021-09-14 University Of Georgia Research Foundation, Inc. Methods of using probenecid for treatment of coronavirus infections

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8400863D0 (en) * 1984-01-13 1984-02-15 Smith Kline French Lab Chemical compounds
DE19632549A1 (de) * 1996-08-13 1998-02-19 Merck Patent Gmbh Arylalkanoylpyridazine
DE19826841A1 (de) * 1998-06-16 1999-12-23 Merck Patent Gmbh Arylalkanoylpyridazine
DE19850701A1 (de) * 1998-11-04 2000-05-11 Merck Patent Gmbh Benzoylpyridazine
DE19932315A1 (de) 1999-07-10 2001-01-11 Merck Patent Gmbh Benzoylpyridazine

Similar Documents

Publication Publication Date Title
JP2005511595A5 (https=)
JP2004517813A5 (https=)
JP2005539054A5 (https=)
JP2013526494A5 (https=)
RU2006118325A (ru) Производные пиразина и их фармацевтическое применение
JP2009533351A5 (https=)
JP2006512301A5 (https=)
JP2009527501A5 (https=)
JP2002520309A5 (https=)
JPS63211266A (ja) ジヒドロピリジン誘導体の中間体
CN1187056C (zh) 环加氧酶抑制剂和脒衍生物的盐、其制备方法、药物应用及其药物组合物
JP2009543836A (ja) インドール化合物
JP2009543835A (ja) インドール化合物
JP2007534702A5 (https=)
CN113121379B (zh) Ampk激动剂化合物或其药学上可接受的盐或酯或溶剂化物及其用途
EP2113502B1 (fr) Composés de type hydrazide et leur utilisation dans des compositions pharmaceutiques pour le traitement des maladies cardiovasculaires
US5100910A (en) Aryl substituted tetrazole derivatives, and application thereof in therapeutics
JP2009543837A (ja) Ep1受容体に対して親和性を有するインドール化合物
US4325964A (en) Phenylamidine derivatives
JP2006522034A5 (https=)
WO2003016313A1 (en) New compounds for treating impotence
US4107286A (en) Polyiods benzene derivatives and X-ray contrast media containing the same
JP2013503170A5 (https=)
RU2008128566A (ru) Органические соединения
JP3468729B2 (ja) 5−リポキシゲナーゼ阻害剤を製造するための方法及び中間体